...

首页> 外文期刊>Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research >DEALING WITH UNCERTAINTY AND ACCOUNTING FOR SOCIAL VALUE JUDGMENTS IN VALUE ASSESSMENTS FOR ORPHAN DRUGS: QUALITATIVE EVIDENCE FROM FOUR EUROPEAN COUNTRIES

【24h】

DEALING WITH UNCERTAINTY AND ACCOUNTING FOR SOCIAL VALUE JUDGMENTS IN VALUE ASSESSMENTS FOR ORPHAN DRUGS: QUALITATIVE EVIDENCE FROM FOUR EUROPEAN COUNTRIES

机译：应对不确定性和会计处理Orphan毒品的价值评估中的社会价值：来自四个欧洲国家的定性证据

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research》 |2016年第3期|共2页
作者
Nicod E.; Brigham Berg K.; Durand-Zaleski I; Kanavos P.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类预防医学、卫生学;
关键词

相似文献

外文文献
中文文献
专利

1. DEALING WITH UNCERTAINTY AND ACCOUNTING FOR SOCIAL VALUE JUDGMENTS IN VALUE ASSESSMENTS FOR ORPHAN DRUGS: QUALITATIVE EVIDENCE FROM FOUR EUROPEAN COUNTRIES [J] . Nicod E., Brigham Berg K., Durand-Zaleski I, Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research . 2016,第3期

机译：应对不确定性和会计处理Orphan毒品的价值评估中的社会价值：来自四个欧洲国家的定性证据
2. RELATIONSHIP BETWEEN ORPHAN DISEASE PREVALENCE, DIFFERENTIAL HTA VALUE ASSESSMENT, AND ORPHAN DRUG PRICING IN SEVEN EUROPEAN COUNTRIES [J] . Sladecek S., Cockerill K., Hegde S., Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research . 2016,第7期

机译：七个欧洲国家的ORPhan疾病患病率，HTA差异价值评估和ORPHAN毒品定价之间的关系
3. Why do health technology assessment coverage recommendations for the same drugs differ across settings? Applying a mixed methods framework to systematically compare orphan drug decisions in four European countries [J] . Nicod Elena The European journal of health economics: HEPAC : health economics in prevention and care . 2017,第6期

机译：为什么健康技术评估覆盖相同药物的建议在环境中有所不同？应用混合方法框架以系统地比较四个欧洲国家的孤儿药物决策
4. Social exclusion and high-speed rail: Some evidence from three European countries [C] . F. Pagliara, L. Biggiero, F. Menicocci AIIT International Congress on Transport Infrastructure and Systems . 2017

机译：社会排斥和高速铁路：来自三个欧洲国家的一些证据
5. Oncology orphan drugs: An evidence assessment, network meta-analysis, and cost-effectiveness analysis. [D] . Cheng, Mindy M. 2012

机译：肿瘤学孤儿药：证据评估，网络荟萃分析和成本效益分析。
6. Why do health technology assessment coverage recommendations for the same drugs differ across settings? Applying a mixed methods framework to systematically compare orphan drug decisions in four European countries [O] . Elena Nicod -1

机译：为什么相同药物的健康技术评估覆盖率建议因环境而异？应用混合方法框架来系统地比较四个欧洲国家中的孤儿药决策
7. Dealing With Uncertainty And Accounting For Social Value Judgments In Value Assessments For Orphan Drugs: Qualitative Evidence From Four European Countries [O] . E. Nicod, K. Berg Brigham, I. Durand-Zaleski, 2016

机译：处理孤儿药物价值评估的不确定性和核算的不确定性和核算：来自四个欧洲国家的定性证据

获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

客服微信
服务号